Jan 2 (Reuters) - Capricor Therapeutics Inc CAPR.O:
CAPRICOR THERAPEUTICS COMPLETES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO THE U.S. FDA FOR DERAMIOCEL FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
CAPRICOR THERAPEUTICS - BLA SUBMISSION TRIGGERS $10 MILLION MILESTONE PAYMENT TO CAPRICOR FROM NIPPON SHINYAKU
Source text: ID:nGNXc1dPKT
Further company coverage: CAPR.O
((Reuters.Briefs@thomsonreuters.com;))